Conduct a comprehensive toxicokinetic study and assessment of the time-dependency of the no-effect level for a simultaneous exposure to melamine and cyanuric acid (the combination of these two compounds is believed to lead to acute renal failure in dogs and cats and may be responsible for the toxicity observed in infants in China).For information on the Center for Veterinary Medicine (CVM) study on the 2007 melamine pet food outbreak see <a href=http://www.youtube.com/user/USFoodandDrugAdmin#p/u/127/I4Uudb3WOOs target=”_blank”>The Melamine Story Video</a>.Melamine and cyanuric acid are believed to have been the suspected toxicants in the major pet food recall in 2007 that led to acute renal failure in dogs and cats. The development of laboratory techniques to assess melamine and cyanuric acid concentrations in rats (which began in 2009) will help to determine the chemical and biochemical properties of melamine and cyanuric acid that influence their toxicity. This will ultimately provide a better understanding of the toxicity mechanisms of food contaminants and the relationship of toxicity to the amount of the substance ingested.This study and assessment will help FDA to determine the chemical and biochemical properties of melamine and cyanuric acid that influence their toxicity and determine the appropriate amounts, if any, that should be allowed in human and animal food.<b>Accomplishment:</b>DBT completed the first of three studies in a comprehensive toxicokinetic study and assessment of the time-dependency of the no-effect level for a simultaneous exposure to melamine and cyanuric acid. The first study was over the course of 7 days and resulted in a manuscript accepted for publication in Toxicological Sciences. The results suggest that the tolerable daily intake values derived from studies conducted with melamine alone may underestimate the risk from coexposures to melamine and cyanuric acid. Researchers hope that this study will help FDA to determine the chemical and biochemical properties of melamine and cyanuric acid that influence their toxicity and determine the appropriate amounts, if any, that should be allowed in human and animal food.maina. Prepare and submit manuscript on the outcome of the 7-day combined melamine and cyanuric rodent study8/15/2010Completed8/6/2010mainb. Publish manuscript in scientific journal10/30/2010Completed10/24/2010COMPLETEDON TRACK<b>Accomplishment:</b>The aim of this study was to determine if urinary biomarkers of acute kidney injury can be used tononinvasively detect renal damage associated with crystal formation in the kidneys ofmelamine and cyanuric acid-exposed rats. The data from this study indicate certain urinary protein biomarkers may serveas a noninvasive biomarker for the detection and monitoring of obstructive nephropathy associated with melamine-cyanuric acid exposure. Early and sensitive biomarkers. of nephrotoxicity are valuable in drug discovery, preclinical safety evaluation of drugsand medical device materials, clinical trials, and evaluation of toxic responses followingexposure to environmental toxicants. Please find the full text, including the abstract, in: http://toxsci.oxfordjournals.org/content/early/2012/05/19/toxsci.kfs182.full.pdf+htmlmaina. Compile and analyze main outcomes of the 28-day combined melamine and cyanuric acid study4/30/2010Completed4/30/2010mainb. Present the main outcomes of the 28-day combined melamine and cyanuric acid study to the TSSRC meeting5/31/2010Completed5/18/2010mainc. Develop draft manuscript on the outcome of the 28-day combined melamine and cyanuric acid study1/30/2011<i>(9/30/2011)</i><i>(TBD)</i>Completed2/10/2012maind. Complete the peer review (NCTR and other researchers) of manuscriptTBDCompleted2/20/2012maine. Obtain NCTR Center Director approval on the draft manuscript via the document tracking systemTBDCompleted3/8/2012mainf. Submit final manuscript on the outcome of the 28-day combined melamine and cyanuric acid study to a scientific journalTBDCompleted3/10/2012ON TRACKON TRACKmaina. Decide upon design of 90-day study5/31/2010Completed5/18/2010mainb. Finalize and submit the 90-day combined melamine and cyanuric acid rat study protocol10/31/2010<i>(12/30/2010)</i>Completed12/18/2010mainc. Complete 90-day combined melamine and cyanuric acid exposure study6/30/2011<i>(12/1/2011)</i>Completed11/9/2011maind. Develop draft report on the outcome of the 90-day combined melamine and cyanuric acid exposure studyTBDNot Yet Startedmaine. Complete the peer review (NCTR and other researchers) of reportTBDNot Yet Startedmainf. Obtain NCTR Center Director approval on the draft report via the document tracking systemTBDNot Yet Startedmaing. Submit NCTR final report on 90-day combined melamine and cyanuric acid exposure studyTBDNot Yet StartedON TRACKON TRACKmaina. Prepare and submit the neonate combined melamine and cyanuric acid study protocol1/30/2011<i>(9/30/2011)</i>Completed3/8/2012mainb. Complete neonate combined melamine and cyanuric acid exposure studyTBDNot Yet Startedmainc. Develop draft report on the outcome of the neonate combined melamine and cyanuric acid exposure studyTBDNot Yet Startedmaind. Complete the peer review (NCTR and other researchers) of reportTBDNot Yet Startedmaine. Obtain NCTR Center Director approval on the draft report via the document tracking systemTBDNot Yet Startedmainf. Submit NCTR final report on the neonate combined melamine and cyanuric acid exposure studyTBDNot Yet Startedhttp://www.fda.gov/AboutFDA/Transparency/track/ucm203296.htmFDA-TRACK NCTR Dashboardhttp://www.fda.gov/AboutFDA/Transparency/track/ucm252974.htmFDA-TRACK Research GlossaryTSSRCToxicology Study Selection and Review Committee਍††਍਍਍਍਍਍਍